Salubritas Therapeutics

Private

Cambridge, MassachusettsHealthcare & Life Scienceshttps://salubritastx.com/

Last Round

Strategic

Dec 23, 2025

Company Overview

Salubritas Therapeutics is a biotechnology company that develops regenerative therapies for hearing loss through sensory hair cell regeneration.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

regenerative medicinesensorineural hearing lossSNHLgene therapyhearing loss treatmentAAV gene therapyRNA therapeuticslipid nanoparticlesLNPdrug discoverybiotech startuphearing restorationsmall-molecule therapeuticsinner ear regenerationpreclinical biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Salubritas Therapeutics Comparables

Compare Salubritas Therapeutics with similar companies based on industry and business-model similarity.

Salubritas Therapeutics comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Echogenesis Therapeutics	83%
AudioCure Pharma	81%
Rinri Therapeutics	80%

View all Comparables

Salubritas Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Strategic	Dec 23, 2025

View all Funding Rounds

Salubritas Therapeutics Investors

Notable investors and investment history

Salubritas Therapeutics investors
Investor	Rounds
Shionogi & Co.	Strategic

View all Investors

Salubritas Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Salubritas Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Salubritas Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts

Employee Range3

Year Founded2021

Last FundingDec 23, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.